Harald Engelhardt
7PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 27, 2025
Discovery of Macrocyclic Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors that Demonstrate Potent Cellular Efficacy and In Vivo Activity in a Mouse Solid Tumor Xenograft Model.James C Tarr, Kyuok Jeon, Nagarathanam Veerasamy
|Aug 05, 2024
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors.James C Tarr, James M Salovich, Martin Aichinger
|Feb 08, 2024
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.Eun Ji Lee, Seung Yeon Oh, You Won Lee
|Jul 26, 2022
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling.Birgit Wilding, Dirk Scharn, Dietrich Böse
|Apr 21, 2022
Therapeutic impact of BET inhibitor BI 894999 treatment: backtranslation from the clinic.Ulrike Tontsch-Grunt, Paula-Elena Traexler, Anke Baum
|May 19, 2020
PI by NMR: Probing CH-π Interactions in Protein-Ligand Complexes by NMR Spectroscopy.Gerald Platzer, Moriz Mayer, Andreas Beier
Pageof 2
Frequent Collaborators
2 joint publications
Nagaraju Miriyala
2 joint publications
Stephen W Fesik
2 joint publications
Flavio Solca
2 joint publications
Darryl B McConnell
2 joint publications
Gerd Bader
1 joint publications
Peter Ettmayer
1 joint publications
Nina Gonnella
1 joint publications
Jonathan T Reeves
1 joint publications
Gerald Platzer
1 joint publications
Andreas Beier
